Please remember that these discussion boards are a public forum, which means open to the public (i.e. non-CSN members) and the content can be found via internet search engines.
Members are strongly advised not to share personal identifiers such as real names, email address, telephone number, street address, etc. This information can be used to identify you and link you to the content you provide.
Other areas of CSN are restricted to members only and cannot be found by search engines.
Multiple Myeloma
Archives for February 2017
Discussion List
Using A Rabbit Virus To Treat Multiple Myeloma
Treating multiple myeloma (MM) with myxoma virus (MYXV) eliminated a majority of malignant cells in preclinical studies, report investigators. Furthermore, introduction of MYXV had no impact on the bone marrow compartment and elicited a strong immune response that eradicated disease in some animals. (source…
New Treatments To Extend Life For Multiple Myeloma Patients
Multiple myeloma patients are now living more than three times as long thanks to new, more effective treatments, and some of the most exciting things are the development of new drugs. (source, details - mmdevelopments.org)
Mylofibrosis
Please need your help
I am heartbroken. My father went through nasal cancer in 2013. I became a member of this site to get advice, tips, ideas on how to help my father through all of this. My dad recently was found to have a tumor on his forehead that went through to the other side of skull (no brain or organ involvement). After the biopsy,…
Private Message Spam
Hello everyone, Thank you to all of you who have alerted us to the PM spamming from earlier today. I apologize for the inconvenience. While we do have securities in place, we are not always able to catch all spam, and we are trying to figure out how this one got around our system. If you received a message from jegac1…
Selinexor for Relapsed/Refractory Multiple Myeloma
recent news item - Patients with relapsed/refractory multiple myeloma (RRMM) for whom prior treatment with lenalidomide, pomalidomide, bortezomib, and carfilzomib fail have few treatment options. Selinexor (KPT-330) is a selective inhibitor of nuclear export (SINE) under development for the treatment of RRMM and other…